GlassScriptPhysician profile
Katherine Maclean
NPI 1417368382
$1,850.91
in general payments reported to CMS, 2019-2025
23 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $85.07 · 2022: $217 · 2023: $514 · 2024: $437 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $338.72 | 2019-2025 | |
| Amgen INC. | $188.25 | 2019-2024 | Prolia, Evenity |
| Baxter Healthcare | $168.44 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $146.38 | 2023-2025 | Myfembree |
| Pfizer INC. | $144.77 | 2022-2024 | |
| Coopersurgical, INC. | $139.83 | 2022-2025 | Paragard T 380a |
| Shield Therapeutics INC | $124.50 | 2023-2024 | Accrufer |
| Mayne Pharma Commercial LLC | $106.38 | 2023-2025 | |
| Astellas Pharma US INC | $105.60 | 2019-2025 | Veozah |
| Sage Therapeutics, LLC | $79.24 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $48.55 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $40.02 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Irhythm Technologies, INC. | $38.81 | 2024 | Zio Xt Patch, Zio Monitor |
| Medtronic, INC. | $24.89 | 2023 | Truclear |
| Organon LLC | $24.72 | 2023-2024 | Nexplanon |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $24.57 | 2019 | |
| Evofem Biosciences, INC. | $20.69 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.80 | 2020 | |
| Aspira Women'S Health INC | $18.89 | 2024 | Ova1 |
| Ferring Pharmaceuticals INC. | $13.36 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.09 | 2019 | |
| Millicent US INC | $11.28 | 2019 | |
| Merck Sharp & Dohme LLC | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Maclean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.